The β3-Adrenergic System and β3-Adrenergic Agonists
- 1 January 2001
- journal article
- review article
- Published by Springer Nature in Reviews in Endocrine and Metabolic Disorders
- Vol. 2 (4) , 385-393
- https://doi.org/10.1023/a:1011852500209
Abstract
No abstract availableThis publication has 57 references indexed in Scilit:
- The tissue distribution of the human β3-adrenoceptor studied using a monoclonal antibody: Direct evidence of the β3-adrenoceptor in human adipose tissue, atrium and skeletal muscleInternational Journal of Obesity, 1999
- Chronic Administration of BRL 26830A for 9 Weeks Improves Insulin Sensitivity but Does not Prevent Weight Gain in Gold-Thioglucose Obese MiceHormone and Metabolic Research, 1999
- %β3adrenergicagonist%SatietyPhysiology & Behavior, 1998
- Lipolytic effects of conventional β3‐adrenoceptor agonists and of CGP 12,177 in rat and human fat cells: preliminary pharmacological evidence for a putative β4‐adrenoceptorBritish Journal of Pharmacology, 1997
- Four β-adrenoceptor subtypes in the mammalian heartPublished by Elsevier ,1997
- Pharmacological characteristics and species‐related variations of β3‐adrenergic receptorsFundamental & Clinical Pharmacology, 1995
- Thermogenesis in MuscleAnnual Review of Physiology, 1994
- Substrate supply for thermogenesis induced by the β-adrenoceptor agonist BRL 26830ACanadian Journal of Physiology and Pharmacology, 1987
- Differences between the effects of noradrenaline and the β-adrenoceptor agonist BRL 28410 in brown adipose tissue and hind limb of the anaesthetized ratCanadian Journal of Physiology and Pharmacology, 1986
- Factors influencing the composition of the weight lost by obese patients on a reducing dietBritish Journal of Nutrition, 1980